PE20080526A1 - Inhibidores de trombina que contienen un grupo aminoisoquinolina - Google Patents

Inhibidores de trombina que contienen un grupo aminoisoquinolina

Info

Publication number
PE20080526A1
PE20080526A1 PE2007001050A PE2007001050A PE20080526A1 PE 20080526 A1 PE20080526 A1 PE 20080526A1 PE 2007001050 A PE2007001050 A PE 2007001050A PE 2007001050 A PE2007001050 A PE 2007001050A PE 20080526 A1 PE20080526 A1 PE 20080526A1
Authority
PE
Peru
Prior art keywords
thrombin inhibitors
inhibitors containing
aminoisoquinoline
group
thrombin
Prior art date
Application number
PE2007001050A
Other languages
English (en)
Inventor
David Jonathan Bennett
Robert Gilfillan
Original Assignee
Organon Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon Nv filed Critical Organon Nv
Publication of PE20080526A1 publication Critical patent/PE20080526A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

SE REFIERE A COMPUESTOS INHIBIDORES DE TROMBINA QUE CONTIENEN UN GRUPO AMINOISOQUINOLINA TALES COMO N-(2-OXO-2-PROPOXIETIL)- -FENIL-D-FENILALANIL-N-[(1-AMINO-6-ISOQUINOLINIL)-METIL]-L-PROLINAMIDA QUE SE ENCUENTRA COMO SAL DICLORHIDRATO, N-(CARBOXIMETIL)- -FENIL-D-FENILALANIL-N-[(1-AMINO-6-ISOQUINOLINIL)-METIL]-L-PROLINAMIDA, ENTRE OTROS. SE REFIERE TAMBIEN A UNA COMPOSICION FARMACEUTICA DE ADMINISTRACION ORAL. DICHOS COMPUESTOS SON UTILES EN EL TRATAMIENTO DE ENFERMEDADES MEDIADAS POR TROMBINA
PE2007001050A 2006-08-08 2007-08-07 Inhibidores de trombina que contienen un grupo aminoisoquinolina PE20080526A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06118608 2006-08-08

Publications (1)

Publication Number Publication Date
PE20080526A1 true PE20080526A1 (es) 2008-06-13

Family

ID=37561257

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2007001050A PE20080526A1 (es) 2006-08-08 2007-08-07 Inhibidores de trombina que contienen un grupo aminoisoquinolina

Country Status (21)

Country Link
US (1) US8299091B2 (es)
EP (1) EP2054402B1 (es)
JP (1) JP5271904B2 (es)
KR (1) KR20090048496A (es)
CN (1) CN101511816B (es)
AR (1) AR062215A1 (es)
AU (1) AU2007283596B2 (es)
BR (1) BRPI0715384A2 (es)
CA (1) CA2659154A1 (es)
CL (1) CL2007002294A1 (es)
CO (1) CO6150148A2 (es)
IL (1) IL196783A (es)
MX (1) MX2009001384A (es)
MY (1) MY143949A (es)
NO (1) NO20090448L (es)
NZ (1) NZ574550A (es)
PE (1) PE20080526A1 (es)
RU (1) RU2437879C2 (es)
TW (1) TWI389899B (es)
WO (1) WO2008017650A1 (es)
ZA (1) ZA200900903B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20150047597A (ko) * 2012-08-27 2015-05-04 어레이 바이오파마 인크. 과증식성 질환의 치료를 위한 세린/트레오닌 키나아제 억제제

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4115468A1 (de) * 1991-05-11 1992-11-12 Behringwerke Ag Amidinophenylalaninderivate, verfahren zu deren herstellung, deren verwendung und diese enthaltende mittel als antikoagulantien
GB9322976D0 (en) * 1993-11-08 1994-01-05 Pfizer Ltd Therapeutic agents
US5523308A (en) * 1995-06-07 1996-06-04 Costanzo; Michael J. Peptidyl heterocycles useful in the treatment of thrombin related disorders
NZ336046A (en) * 1996-12-06 2000-10-27 Cortech Inc Serine protease inhibitors containing substituted oxadiazole, thiadiazole and triazole peptide derivatives
IL123986A (en) * 1997-04-24 2011-10-31 Organon Nv Medicinal compounds
TW575567B (en) 1998-10-23 2004-02-11 Akzo Nobel Nv Serine protease inhibitor
EP1303491A1 (en) * 2000-07-12 2003-04-23 Akzo Nobel N.V. Thrombin inhibitors comprising an aminoisoquinoline group

Also Published As

Publication number Publication date
CA2659154A1 (en) 2008-02-14
JP5271904B2 (ja) 2013-08-21
BRPI0715384A2 (pt) 2013-06-18
WO2008017650A1 (en) 2008-02-14
RU2009107917A (ru) 2010-09-20
AU2007283596A1 (en) 2008-02-14
IL196783A (en) 2013-03-24
AR062215A1 (es) 2008-10-22
CL2007002294A1 (es) 2008-04-18
CN101511816B (zh) 2013-01-02
ZA200900903B (en) 2010-06-30
TWI389899B (zh) 2013-03-21
NO20090448L (no) 2009-02-05
KR20090048496A (ko) 2009-05-13
EP2054402A1 (en) 2009-05-06
US20100305153A1 (en) 2010-12-02
JP2010500321A (ja) 2010-01-07
MX2009001384A (es) 2009-04-30
AU2007283596B2 (en) 2012-07-05
TW200821294A (en) 2008-05-16
NZ574550A (en) 2010-09-30
CO6150148A2 (es) 2010-04-20
RU2437879C2 (ru) 2011-12-27
EP2054402B1 (en) 2013-11-27
MY143949A (en) 2011-07-29
US8299091B2 (en) 2012-10-30
CN101511816A (zh) 2009-08-19
IL196783A0 (en) 2009-11-18

Similar Documents

Publication Publication Date Title
CO6382125A2 (es) Inhibidores de proteína quinasa
MA32257B1 (fr) Hydroxymethyl pyrrolidines comme agonistes des recepteurs beta-3- adrenergiques.
EA201101618A1 (ru) Арилпиридины в качестве ингибиторов альдостеронсинтазы
EA201170508A1 (ru) Производные 1-амино-2-циклобутилэтилбороновой кислоты
EA201290183A1 (ru) Бензодиазепиновый ингибитор бромодомена
EA201692506A3 (ru) Ингибиторы репликации вирусов гриппа
EA201290089A1 (ru) Химические соединения
EA201291356A1 (ru) Пиперидиноновые производные как ингибиторы mdm2 для лечения рака
EA201490272A1 (ru) Новые 4-пиперидинильные соединения для применения в качестве ингибиторов танкиразы
SV2011004077A (es) Derivados aminobutiricos sustituidos como inhibidores de neprilisina
EA201000958A1 (ru) Пептидилнитрилы и их применение в качестве ингибиторов дипептидилпептидазы i
EA201391720A1 (ru) Замещенные диоксопиперидинилфталимидные производные
EA201100138A1 (ru) 4-феноксиметилпиперидины в качестве модуляторов активности gpr119
EA201290416A1 (ru) Новые спиропиперидиновые соединения
EA201170753A1 (ru) Налмефена гидрохлорид дигидрат
EA201200570A1 (ru) Соединения и композиции в качестве модуляторов активности gpr119
EA201001196A1 (ru) Соединения 4-пиридинона и их применение для лечения рака
EA201070442A1 (ru) НОВЫЕ ИНГИБИТОРЫ sEH И ИХ ПРИМЕНЕНИЕ
ATE554084T1 (de) N-hydroxyacrylamidverbindungen
CR20140412A (es) Inhibidores de la metalproteinasa matriz
PH12013501321A1 (en) Phenoxymethyl heterocyclic compounds
UY33870A (es) Compuesto para el tratamiento de disfunción cognitiva en esquizofrenia, sus usos y composición que lo contiene
EA201490573A1 (ru) Соединение бензотиазолона
EA201000063A1 (ru) Новые соединения, обладающие функцией ингибиторов тромбина, и фармацевтические композиции на их основе
PE20080526A1 (es) Inhibidores de trombina que contienen un grupo aminoisoquinolina

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed